In this new series reviewing recent developments in market access, we highlight publications investigating health technology assessment (HTA) guidance, review processes and outcomes across the world and discuss how forthcoming changes in the HTA and regulatory environment in the European Union may allow for more consistency in decision making.
No takes yet. Share an insight, caveat, or question.
Gilardino et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: